Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 7/20 | 0.54 |
| ▸ | ESR1 | P03372 | 8/20 | 0.50 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.50 |
| ▸ | USP7 | Q93009 | 1/20 | 0.50 |
| ▸ | ABL1 | P00519 | 2/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.46 |
| ▸ | BCR | P11274 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | ESRRA | P11474 | 1/20 | 0.45 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28204878 | 0.93 | ESR2 (0.52) | ESR2ESR1HSD17B1USP7ABL1 | |
| SCHEMBL10190451 | 0.92 | ESR2 (0.56) | ESR2ESR1HSD17B1USP7ABL1 | |
| SCHEMBL17625680 | 0.86 | GAA (0.54) | ESR2ESR1HSD17B1USP7ABL1 | |
| SCHEMBL15929640 | 0.86 | ACHE (0.59) | ESR2ESR1HSD17B1ABL1ABCB1 | |
| SCHEMBL20147811 | 0.84 | ESR2 (0.50) | ESR2ESR1HSD17B1USP7ABL1 | |
| SCHEMBL29738442 | 0.83 | ESR2 (0.76) | ESR2ESR1HSD17B1 | |
| SCHEMBL439874 | 0.83 | ESR2 (0.76) | ESR2ESR1HSD17B1 | |
| SCHEMBL1759436 | 0.82 | ESR2 (0.47) | ESR2ESR1HSD17B1ABL1ABCB1 | |
| SCHEMBL3817112 | 0.82 | KDM4E (0.54) | ESR2ESR1HSD17B1ABL1ABCB1 | |
| SCHEMBL3669243 | 0.81 | ESR1 (0.50) | ESR2ESR1HSD17B1USP7ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119954746-A | Epoxy resin | 波音公司 | 2025-05-09 | — | — | CN | disclosed |
| US-20230312812-A1 | EPOXY RESIN | THE BOEING COMPANY | 2023-10-05 | — | — | US | disclosed |
| US-11718707-B2 | Epoxy resin | THE BOEING COMPANY (US) | 2023-08-08 | — | — | US | disclosed |
| EP-4148047-A1 | EPOXY RESIN | The Boeing Company (US) | 2023-03-15 | — | — | EP | disclosed |
| CN-115057991-A | Epoxy resin | 波音公司 | 2022-09-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718707-B2 | Epoxy resin | EPHX2, EPHX1, CBR1 | ESR2 163/4885ESR1 228/4885HSD17B1 3944/4885 |
| US-20230312812-A1 | EPOXY RESIN | EPHX2, EPHX1, CBR1 | ESR2 163/4885ESR1 228/4885HSD17B1 3944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.